Yakang Biotech: Abnormal fluctuations in stock trading; there is no undisclosed significant information that should be disclosed.

YaoKang Biotech announced that the company's stock price had a cumulative deviation of over 30% over two consecutive trading days on August 7 and August 10, 2026, indicating an abnormal fluctuation. After conducting a self-examination and verifying with the controlling shareholder and actual controller, as of the announcement date, the company and relevant parties do not have any significant information that should have been disclosed but has not been disclosed. The company's operations are currently normal, and there have been no significant changes. The company reminds investors to pay attention to stock price fluctuations and trading risks and to invest rationally.